1-20 of 334689
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Clinical Trials & Observations
Journal: Blood
Blood (2026) 147 (2): 97–98.
Published: 2026
Journal Articles
Journal Articles
Journal: Blood
Blood (2026) 147 (2): 115–126.
Published: 2026
Journal Articles
Journal Articles
Clinical Trials & Observations
Journal: Blood
Blood (2026) 147 (2): 127–137.
Published: 2026
Journal Articles
Journal Articles
Journal Articles
Journal: Blood
Blood (2026) 147 (2): 105–114.
Published: 2026
Includes: Supplemental data
Journal Articles
Journal Articles
Images
Images
“Cross-correction” of PNP deficiency in neuronal cells after allogeneic HCT. In the recipient’s PNP-deficient neurons, the absence of functional PNP enzyme prevents the phosphorolysis of substrates such as deoxyguanosine (dGuo) into hypoxanthine, leading to accumulation of dGTP. This disrupts the cell’s metabolism and leads to the cell’s apoptosis. Excess dGuo can also exit the cell through transmembrane NT. After transplantation, excess dGuo is taken up by the donor PNP-proficient blood cell across the blood-brain barrier, following the concentration gradient of dGuo, where it can be further metabolized, eventually leading to the restoration of purine metabolism in the neuron. dGTP, deoxyguanosine triphosphate; NT, nucleoside transporters. Figure created with BioRender.com. Grunebaum E. (2025) https://app.biorender.com/illustrations/689a34dde8409e308ef5ce82.
Published: 2026
“Cross-correction” of PNP deficiency in neuronal cells after allogeneic HCT. In the recipient’s PNP-deficient neurons, the absence of functional PNP enzyme prevents the phosphorolysis of substrates such as deoxyguanosine (dGuo) into hypoxanthine, leading to accumulation of dGTP. This disrupts the ce... More about this image found in “Cross-correction” of PNP deficiency in neuronal cells after allogeneic HCT...
Images
Overview of contributors to TC. TL reflects the physical length of telomeric DNA repeats at the natural ends of chromosomes, which can be measured using methods such as TRF, flow-FISH, STELA, and long-read WGS. TC measures the total amount of telomeric DNA repeats and may include sources such as intrachromosomal telomeric insertions and neotelomeres formed at double-strand break sites. TC can be measured by methods like (qPCR), short-read WGS, and long-read WGS. Flow-FISH, flow cytometry–based fluorescence in situ hybridization; qPCR, quantitative polymerase chain reaction; STELA, single telomere length analysis; TRF, telomere restriction fragment. Figure created with BioRender. Tiong IS. (2025) https://BioRender.com/yg8q9ug.
Published: 2026
Overview of contributors to TC. TL reflects the physical length of telomeric DNA repeats at the natural ends of chromosomes, which can be measured using methods such as TRF, flow-FISH, STELA, and long-read WGS. TC measures the total amount of telomeric DNA repeats and may include sources such as int... More about this image found in Overview of contributors to TC. TL reflects the physical length of telomeri...
Images
Outcome measures of the 72 patients with HGBCL-11q that were studied. (A) EFS and (B) OS of the 72 patients with HGBCL-11q. (C) EFS and (D) OS of the 60 patients with HGBCL-11q without a preexisting disorder compared with those of the 12 patients with HGBCL-11q with a preexisting disorder. pt, patient; SML, second malignancy.
Published: 2026
Figure 1. Outcome measures of the 72 patients with HGBCL-11q that were studied. (A) EFS and (B) OS of the 72 patients with HGBCL-11q. (C) EFS and (D) OS of the 60 patients with HGBCL-11q without a preexisting disorder compared with those of the 12 patients with HGBCL-11q with a preexisting disor... More about this image found in Outcome measures of the 72 patients with HGBCL-11q that were studied. (A) ...